OpalGenix, Inc


OpalGenix specializes in personalized pain management solutions, leveraging genetic signature-based prediction and clinical decision support to optimize opioid therapy. Their mission is to maximize pain relief while minimizing adverse effects and safety risks associated with opioid use, through innovative pharmacogenetic testing and analytics.

Industries

biotechnology
health-care
hospital-650c
medical

Nr. of Employees

small (1-50)

OpalGenix, Inc

612 Pomeroy St, Indianapolis, IN 46202


Products

Pre-operative pharmacogenetic risk test and clinical decision support

A pre-operative laboratory-developed pharmacogenetic test combined with analytics that produces a clinician report to guide opioid selection, precision dosing, monitoring and follow-up to reduce opioid-related adverse outcomes.


Services

Laboratory service that performs pharmacogene genotyping and delivers clinician-facing reports with risk stratification and prescribing recommendations for perioperative opioid management.

Support for integrating genotype-informed decision support into clinical workflows to inform prescribing, monitoring, and follow-up in perioperative settings.

Collaboration on NIH‑funded and investigator-initiated clinical research projects evaluating pharmacogenetic predictors of opioid response and perioperative outcomes.

Expertise Areas

  • Pharmacogenomics
  • Perioperative pain management
  • Clinical decision support for prescribing
  • Predictive algorithm development and validation
  • Show More (4)

Key Technologies

  • Pharmacogene genotyping panels
  • Polygenic risk scoring / multi-gene signature development
  • Clinical decision support algorithms
  • Bioinformatics and predictive statistical modeling
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.